Type 2 Diabetes

Exercise Protocol Improves Outcomes in T2D

Exercise Protocol Improves Outcomes in T2D

By

Exercise regimens were prescribed based on individual disease states: diabetes without complications, diabetic retinopathy, diabetic nephropathy, diabetic autonomic neuropathy, or diabetic peripheral neuropathy.

Type 2 Diabetes Death and CV Events Predicted by Systolic Blood Pressure Variability

Type 2 Diabetes Death and CV Events Predicted by Systolic Blood Pressure Variability

By

For patients with type 2 diabetes, visit-to-visit variability in systolic blood pressure may function as an independent predictor for cardiovascular events.

ADA: Clinical Benefit With Alirocumab in T2D Plus Statin Therapy

ADA: Clinical Benefit With Alirocumab in T2D Plus Statin Therapy

By

Researchers presented data from the ODYSSEY DM Insulin and Dyslipidemia trials at ADA 2017.

Semaglutide Improved Beta-Cell Function and Glycemic Control in Type 2 Diabetes

Semaglutide Improved Beta-Cell Function and Glycemic Control in Type 2 Diabetes

By

Semaglutide significantly increased insulin response and was well-tolerated in patients with type 2 diabetes.

Cardiometabolic Disease Staging Score Useful in Quantifying T2D Risk in Overweight, Obesity

Cardiometabolic Disease Staging Score Useful in Quantifying T2D Risk in Overweight, Obesity

Cardiometabolic Disease Staging scores can be used to quantify diabetes risk and assess efficacy of weight loss pharmacotherapy in obesity.

Improving Glycemic Control in T2D With Text Message Intervention

Improving Glycemic Control in T2D With Text Message Intervention

Three-times daily text messages over a 6 month period were found to improve glycemic control vs usual care.

Blood Glucose Self-Monitoring in Type 2 Diabetes Does Not Benefit Glycemic Control

Blood Glucose Self-Monitoring in Type 2 Diabetes Does Not Benefit Glycemic Control

By

There were no significant differences in hemoglobin A1c across the 3 self-monitoring blood glucose groups.

Pooled Analysis Demonstrates Safety, Tolerability of Empagliflozin

Pooled Analysis Demonstrates Safety, Tolerability of Empagliflozin

A pooled analysis examined the rates of amputation and fracture in patients with type 2 diabetes prescribed empagliflozin.

FDA: Application Submitted for CV Safety Data Review of Insulin Degludec

FDA: Application Submitted for CV Safety Data Review of Insulin Degludec

By

The FDA is poised to review data from the DEVOTE trial, examining the rates of major adverse cardiovascular events in insulin degludec vs insulin glargine.

Cruciferous Vegetables May Regulate Dysglcemia In Obesity With T2D

Cruciferous Vegetables May Regulate Dysglcemia In Obesity With T2D

Sulforaphane extract from cruciferous vegetables aids in dysglycemia regulation in patients with obesity and type 2 diabetes.

Extended-Release Naltrexone/Bupropion Efficacious for Weight Loss in Type 2 Diabetes

Extended-Release Naltrexone/Bupropion Efficacious for Weight Loss in Type 2 Diabetes

By

Two studies examined the effects of naltrexone/bupropion on weight loss, glycemic parameters, and cardiovascular risks in patients with type 2 diabetes.

Liraglutide Does Not Increase Risk for Acute Pancreatitis in Type 2 Diabetes

Liraglutide Does Not Increase Risk for Acute Pancreatitis in Type 2 Diabetes

By

Liraglutide does not increase the risk for acute pancreatitis in patients with type 2 diabetes who are also at high risk for cardiovascular events.

Diabetic Retinopathy Caused by Sleep Apnea in T2D

Diabetic Retinopathy Caused by Sleep Apnea in T2D

Sleep apnea was independently linked to sight-threatening diabetic retinopathy in type 2 diabetes.

Hepatitis C Virus: An Increased Risk For Type 2 Diabetes

Hepatitis C Virus: An Increased Risk For Type 2 Diabetes

By

Type 2 diabetes risk appears to be increased in patients with hepatitis C virus and related disorders.

Does Vitamin D Supplementation Impact Insulin Sensitivity in T2D?

Does Vitamin D Supplementation Impact Insulin Sensitivity in T2D?

No difference was noted among groups related to insulin sensitivity following vitamin D supplementation.

Increased Burden of Care With Diabetic Foot Ulcers, Infections

Increased Burden of Care With Diabetic Foot Ulcers, Infections

Diabetic foot ulcers correlated with a 3.4-fold increase in the odds of a patient needing an emergency department referral.

Glycemic Control and Mortality Risk With Statins in Type 2 Diabetes

Glycemic Control and Mortality Risk With Statins in Type 2 Diabetes

By

Patients with type 2 diabetes taking statins after insulin initiation had better glycemic control, but their risk for mortality was higher compared with patients who did not take statins.

Orthostatic Hypotension In Type 2 Diabetes Increases CV, Cerebrovascular Events

Orthostatic Hypotension In Type 2 Diabetes Increases CV, Cerebrovascular Events

Riser patterns in patients' BP resulting from orthostatic hypotension has been linked to increased rates of mortality and major adverse cardiac and cerebrovascular events.

Ertugliflozin Plus Metformin Improves Glycemic Control in Type 2 Diabetes

Ertugliflozin Plus Metformin Improves Glycemic Control in Type 2 Diabetes

By

A randomized double-blind trial examined the safety and efficacy of ertugliflozin plus metformin for inadequately controlled type 2 diabetes.

Obesity, Type 2 Diabetes Have Negative Effects on Brain Function

Obesity, Type 2 Diabetes Have Negative Effects on Brain Function

Obesity negatively affects brain function, particularly in patients with type 2 diabetes.

Maternal Type 2 and Gestational Diabetes Lead to Increased Asthma Risk for Offspring

Maternal Type 2 and Gestational Diabetes Lead to Increased Asthma Risk for Offspring

By

Researchers examined the relationship between maternal diabetes and asthma risk in children.

Device-Supported vs Routine Titration in Type 2 Diabetes

Device-Supported vs Routine Titration in Type 2 Diabetes

By

More patients in the device-supported group achieved a fasting self-monitored plasma glucose target of 90 to 130 mg/dL at week 16 without severe hypoglycemia.

Transition-of-Care Algorithm Performs Well in Surgery Patients With Type 2 Diabetes

Transition-of-Care Algorithm Performs Well in Surgery Patients With Type 2 Diabetes

By

HbA1c fell from 7.9%±2.0% at admission to 7.1%±1.5% at 3 months after discharge.

New Point-of-Care C Peptide Test Shows Promise

New Point-of-Care C Peptide Test Shows Promise

By

A new point-of-care C peptide test may increase ease and access to testing for patients with type 1 and type 2 diabetes.

Canagliflozin Reduces Cardiovascular Stress In Older Patients With Type 2 Diabetes

Canagliflozin Reduces Cardiovascular Stress In Older Patients With Type 2 Diabetes

By

Canagliflozin reduced levels of cardiovascular stress biomarkers N-terminal pro-B type natriuretic peptide and high sensitivity troponin I.

Ezetimibe Reduces LDL-C, Colesevelam Reduces HbA1c in Type 2 Diabetes

Ezetimibe Reduces LDL-C, Colesevelam Reduces HbA1c in Type 2 Diabetes

By

At 3 months, ezetimibe produced greater reductions in LDL cholesterol, whereas colesevelam produced greater reductions in HbA1c levels.

Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes

Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes

By

At 12 years of testosterone treatment, HbA1c decreased to 5.5±0.3%.

Dapagliflozin Improves Endothelial Function in Type 2 Diabetes

Dapagliflozin Improves Endothelial Function in Type 2 Diabetes

By

Flow mediated dilation changes improved in patients who received dapagliflozin.

Nerve Decompression Potentially Beneficial  in Painful Diabetic Neuropathy

Nerve Decompression Potentially Beneficial in Painful Diabetic Neuropathy

By

Researchers assessed whether neurolysis could alleviate pain associated with diabetic neuropathy.

Obesity Severity Linked to Increased Incidence of Type 2 Diabetes in Children

Obesity Severity Linked to Increased Incidence of Type 2 Diabetes in Children

By

American Indian youth with increasingly severe obesity had a significantly higher risk of type 2 diabetes incidence.

Sign Up for Free e-Newsletters